Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Krammer

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Nature|October 26, 2000
CD95's deadly mission in the immune systemP H Krammer
Pharmazie in Unserer Zeit|November 1, 1996
[Apoptosis in the immune system: murder or suicide]P H Krammer
Cell Death and Differentiation|July 1, 1997
The tumor strikes back: new data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunologyP H Krammer
Toxicology Letters|February 18, 1999
The CD95(APO-1/Fas)/CD95L systemP H Krammer
The Journal of Experimental Medicine|January 1, 1978
Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptorsP H Krammer
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1981
MHC restriction and T cell receptorsP H Krammer
Cell Death and Differentiation|April 1, 1996
The CD95(APO-1/Fas) receptor/ligand system: death signals and diseasesP H Krammer
Current Topics in Microbiology and Immunology|January 1, 1981
The T-cell receptor problemP H Krammer
Advances in Immunology|January 26, 1999
CD95(APO-1/Fas)-mediated apoptosis: live and let dieP H Krammer
Experimental Cell Research|March 31, 2000
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systemsH Walczak, P H Krammer
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Nature|October 26, 2000
CD95's deadly mission in the immune systemP H Krammer
Pharmazie in Unserer Zeit|November 1, 1996
[Apoptosis in the immune system: murder or suicide]P H Krammer
Cell Death and Differentiation|July 1, 1997
The tumor strikes back: new data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunologyP H Krammer
Toxicology Letters|February 18, 1999
The CD95(APO-1/Fas)/CD95L systemP H Krammer
The Journal of Experimental Medicine|January 1, 1978
Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptorsP H Krammer
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1981
MHC restriction and T cell receptorsP H Krammer
Cell Death and Differentiation|April 1, 1996
The CD95(APO-1/Fas) receptor/ligand system: death signals and diseasesP H Krammer
Current Topics in Microbiology and Immunology|January 1, 1981
The T-cell receptor problemP H Krammer
Advances in Immunology|January 26, 1999
CD95(APO-1/Fas)-mediated apoptosis: live and let dieP H Krammer
Experimental Cell Research|March 31, 2000
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systemsH Walczak, P H Krammer
Pageof 30